Catalyst Wire Dossier Catalyst Wire Dossier

INAQOVI

cedazuridine; decitabine · Otsuka Pharmaceutical Netherlands B.V.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for INAQOVI, covering 2025-03-10 to 2026-07-17. Get the full timeline:

Most recent: EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.

See pricing